Media Center
Press Releases

Press Releases

27 Jan 16
Pharma Companies Must Do Research to Keep Up with Shifts in the Global Market Access Landscape

As the overall costs of drugs continue to increase and pricing pressures shift the dynamics of the healthcare market, pharmaceutical companies must analyze real-world trends in different treatment spaces, and assess existing and expected levels of competition, in order to gain optimal market access, says business intelligence provider GBI Research.

Read post
20 Jan 16
Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Will Exceed $10 Billion by 2021

The treatment market for Type 2 Diabetes Mellitus (T2DM) in the Asia-Pacific (APAC) region will increase from a little under $6.1 billion in 2014 to just over $10 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 7.7%, according to business intelligence provider GBI Research.

Read post
14 Jan 16
Chronic Obstructive Pulmonary Disease Treatment Pipeline Lacks Robust Innovation, says GBI Research

Despite an influx of new therapies over recent years, the Chronic Obstructive Pulmonary Disease (COPD) treatment market has a number of unmet needs, and the innovation in its product development pipeline is lagging in comparison to other indications, says business intelligence provider GBI Research.

Read post
12 Jan 16
Parkinson’s Disease Treatment Pipeline Holds Significant Potential for Patients and Investors

The Parkinson’s disease treatment pipeline presents a distinctly more promising landscape than the current market, which is burdened with unmet needs and a lack of disease-modifying drugs, says business intelligence provider GBI Research.

Read post
07 Jan 16
Demand for Biobanking Resources Continues to Increase Despite Ethical and Financial Concerns

The demand for biobanks, organizations which collect human biospecimens and associated data for medical-scientific research, is increasing in North America and Europe despite various ethical and financial concerns, according to business intelligence provider GBI Research.

Read post